Meconium-stained amniotic fluid: Increased risk for adverse neonatal outcome

M. D. Berkus, O. Langer, A. Samueloff, E. M J Xenakis, Nancy T Field, L. E. Ridgeway

Research output: Contribution to journalArticle

77 Citations (Scopus)

Abstract

Objective: To determine the risk of adverse neonatal outcome associated with meconium-stained amniotic fluid independent of that related to antepartum or intrapartum abnormalities. Methods: A cohort of 2200 consecutive deliveries was examined and the fetal heart rate (FHR) tracings analyzed independently. Singleton term pregnancies without fatal malformations were stratified by the consistency of meconium and compared. Results: Moderate or thick meconium increased the risk for adverse outcome more than threefold (relative risk 3.2, 95% confidence interval 2.0-5.2). This risk was independent of fetal heart tracing abnormalities or maternal hypertensive, kidney, or heart disease. Conclusion: Thick meconium alone should alert the physician to a high-risk fetal condition. This phenomenon requires continuous FHR monitoring and reassurance of fetal well-being by acid-base assessment or the equivalent, regardless of maternal disease status or the presence of abnormal FHR tracings.

Original languageEnglish (US)
Pages (from-to)115-120
Number of pages6
JournalObstetrics and Gynecology
Volume84
Issue number1
StatePublished - 1994
Externally publishedYes

Fingerprint

Meconium
Amniotic Fluid
Fetal Heart Rate
Mothers
Fetal Monitoring
Fetal Heart
Congenital Heart Defects
Kidney Diseases
Heart Diseases
Confidence Intervals
Physicians
Pregnancy
Acids

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Berkus, M. D., Langer, O., Samueloff, A., Xenakis, E. M. J., Field, N. T., & Ridgeway, L. E. (1994). Meconium-stained amniotic fluid: Increased risk for adverse neonatal outcome. Obstetrics and Gynecology, 84(1), 115-120.

Meconium-stained amniotic fluid : Increased risk for adverse neonatal outcome. / Berkus, M. D.; Langer, O.; Samueloff, A.; Xenakis, E. M J; Field, Nancy T; Ridgeway, L. E.

In: Obstetrics and Gynecology, Vol. 84, No. 1, 1994, p. 115-120.

Research output: Contribution to journalArticle

Berkus, MD, Langer, O, Samueloff, A, Xenakis, EMJ, Field, NT & Ridgeway, LE 1994, 'Meconium-stained amniotic fluid: Increased risk for adverse neonatal outcome', Obstetrics and Gynecology, vol. 84, no. 1, pp. 115-120.
Berkus MD, Langer O, Samueloff A, Xenakis EMJ, Field NT, Ridgeway LE. Meconium-stained amniotic fluid: Increased risk for adverse neonatal outcome. Obstetrics and Gynecology. 1994;84(1):115-120.
Berkus, M. D. ; Langer, O. ; Samueloff, A. ; Xenakis, E. M J ; Field, Nancy T ; Ridgeway, L. E. / Meconium-stained amniotic fluid : Increased risk for adverse neonatal outcome. In: Obstetrics and Gynecology. 1994 ; Vol. 84, No. 1. pp. 115-120.
@article{cdd83991ad1147f78d618abfcf703cb1,
title = "Meconium-stained amniotic fluid: Increased risk for adverse neonatal outcome",
abstract = "Objective: To determine the risk of adverse neonatal outcome associated with meconium-stained amniotic fluid independent of that related to antepartum or intrapartum abnormalities. Methods: A cohort of 2200 consecutive deliveries was examined and the fetal heart rate (FHR) tracings analyzed independently. Singleton term pregnancies without fatal malformations were stratified by the consistency of meconium and compared. Results: Moderate or thick meconium increased the risk for adverse outcome more than threefold (relative risk 3.2, 95{\%} confidence interval 2.0-5.2). This risk was independent of fetal heart tracing abnormalities or maternal hypertensive, kidney, or heart disease. Conclusion: Thick meconium alone should alert the physician to a high-risk fetal condition. This phenomenon requires continuous FHR monitoring and reassurance of fetal well-being by acid-base assessment or the equivalent, regardless of maternal disease status or the presence of abnormal FHR tracings.",
author = "Berkus, {M. D.} and O. Langer and A. Samueloff and Xenakis, {E. M J} and Field, {Nancy T} and Ridgeway, {L. E.}",
year = "1994",
language = "English (US)",
volume = "84",
pages = "115--120",
journal = "Obstetrics and Gynecology",
issn = "0029-7844",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Meconium-stained amniotic fluid

T2 - Increased risk for adverse neonatal outcome

AU - Berkus, M. D.

AU - Langer, O.

AU - Samueloff, A.

AU - Xenakis, E. M J

AU - Field, Nancy T

AU - Ridgeway, L. E.

PY - 1994

Y1 - 1994

N2 - Objective: To determine the risk of adverse neonatal outcome associated with meconium-stained amniotic fluid independent of that related to antepartum or intrapartum abnormalities. Methods: A cohort of 2200 consecutive deliveries was examined and the fetal heart rate (FHR) tracings analyzed independently. Singleton term pregnancies without fatal malformations were stratified by the consistency of meconium and compared. Results: Moderate or thick meconium increased the risk for adverse outcome more than threefold (relative risk 3.2, 95% confidence interval 2.0-5.2). This risk was independent of fetal heart tracing abnormalities or maternal hypertensive, kidney, or heart disease. Conclusion: Thick meconium alone should alert the physician to a high-risk fetal condition. This phenomenon requires continuous FHR monitoring and reassurance of fetal well-being by acid-base assessment or the equivalent, regardless of maternal disease status or the presence of abnormal FHR tracings.

AB - Objective: To determine the risk of adverse neonatal outcome associated with meconium-stained amniotic fluid independent of that related to antepartum or intrapartum abnormalities. Methods: A cohort of 2200 consecutive deliveries was examined and the fetal heart rate (FHR) tracings analyzed independently. Singleton term pregnancies without fatal malformations were stratified by the consistency of meconium and compared. Results: Moderate or thick meconium increased the risk for adverse outcome more than threefold (relative risk 3.2, 95% confidence interval 2.0-5.2). This risk was independent of fetal heart tracing abnormalities or maternal hypertensive, kidney, or heart disease. Conclusion: Thick meconium alone should alert the physician to a high-risk fetal condition. This phenomenon requires continuous FHR monitoring and reassurance of fetal well-being by acid-base assessment or the equivalent, regardless of maternal disease status or the presence of abnormal FHR tracings.

UR - http://www.scopus.com/inward/record.url?scp=0028359850&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028359850&partnerID=8YFLogxK

M3 - Article

C2 - 8008304

AN - SCOPUS:0028359850

VL - 84

SP - 115

EP - 120

JO - Obstetrics and Gynecology

JF - Obstetrics and Gynecology

SN - 0029-7844

IS - 1

ER -